Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Scanlon

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Journal of Neuro-Oncology|July 23, 2024
Sonodynamic therapy for adult-type diffuse gliomas: past, present, and futureSydney E Scanlon, Regan M Shanahan, Othman Bin-Alamer, et al.
Healthcare (Basel, Switzerland)|July 12, 2025
Exercise Specialists' Evaluation of Robot-Led Rehabilitative Exercise for People with Parkinson's DiseaseMatthew Lamsey, Meredith D Wells, Lydia Hamby, et al.
Genes, Brain, and Behavior|March 31, 2021
Anxiety-related defensive behavioral responses in mice selectively bred for High and Low ActivityWinona C Booher, Lucy A Hall, Aimee L Thomas, et al.
Molecular Therapy. Nucleic Acids|December 17, 2017
Anti-tumor Activity of miniPEG-γ-Modified PNAs to Inhibit MicroRNA-210 for Cancer TherapyAnisha Gupta, Elias Quijano, Yanfeng Liu, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 7, 2024
Vascular contributions to cognitive decline: Beyond amyloid and tau in the Harvard Aging Brain StudyZahra Shirzadi, Rory Boyle, Wai-Ying W Yau, et al.
Science Translational Medicine|February 3, 2017
2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivityParker L Sulkowski, Christopher D Corso, Nathaniel D Robinson, et al.
ESMO Open|October 12, 2024
Immune microenvironment modulation following neoadjuvant therapy for oesophageal adenocarcinoma: a translational analysis of the DEBIOC clinical trialE Scanlon, A Lavery, M Albraikat, et al.
JCO Precision Oncology|August 9, 2018
Transcriptional subtyping and CD8 immunohistochemistry identifies poor prognosis stage II/III colorectal cancer patients who benefit from adjuvant chemotherapyW L Allen, P D Dunne, S McDade, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2020
Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion-Positive Lung Cancer by Combining Selpercatinib with CrizotinibEzra Y Rosen, Melissa L Johnson, Sarah E Clifford, et al.
Alzheimer'S Research & Therapy|July 3, 2024
Identifying longitudinal cognitive resilience from cross-sectional amyloid, tau, and neurodegenerationRory Boyle, Diana L Townsend, Hannah M Klinger, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Journal of Neuro-Oncology|July 23, 2024
Sonodynamic therapy for adult-type diffuse gliomas: past, present, and futureSydney E Scanlon, Regan M Shanahan, Othman Bin-Alamer, et al.
Healthcare (Basel, Switzerland)|July 12, 2025
Exercise Specialists' Evaluation of Robot-Led Rehabilitative Exercise for People with Parkinson's DiseaseMatthew Lamsey, Meredith D Wells, Lydia Hamby, et al.
Genes, Brain, and Behavior|March 31, 2021
Anxiety-related defensive behavioral responses in mice selectively bred for High and Low ActivityWinona C Booher, Lucy A Hall, Aimee L Thomas, et al.
Molecular Therapy. Nucleic Acids|December 17, 2017
Anti-tumor Activity of miniPEG-γ-Modified PNAs to Inhibit MicroRNA-210 for Cancer TherapyAnisha Gupta, Elias Quijano, Yanfeng Liu, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 7, 2024
Vascular contributions to cognitive decline: Beyond amyloid and tau in the Harvard Aging Brain StudyZahra Shirzadi, Rory Boyle, Wai-Ying W Yau, et al.
Science Translational Medicine|February 3, 2017
2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivityParker L Sulkowski, Christopher D Corso, Nathaniel D Robinson, et al.
ESMO Open|October 12, 2024
Immune microenvironment modulation following neoadjuvant therapy for oesophageal adenocarcinoma: a translational analysis of the DEBIOC clinical trialE Scanlon, A Lavery, M Albraikat, et al.
JCO Precision Oncology|August 9, 2018
Transcriptional subtyping and CD8 immunohistochemistry identifies poor prognosis stage II/III colorectal cancer patients who benefit from adjuvant chemotherapyW L Allen, P D Dunne, S McDade, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2020
Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion-Positive Lung Cancer by Combining Selpercatinib with CrizotinibEzra Y Rosen, Melissa L Johnson, Sarah E Clifford, et al.
Alzheimer'S Research & Therapy|July 3, 2024
Identifying longitudinal cognitive resilience from cross-sectional amyloid, tau, and neurodegenerationRory Boyle, Diana L Townsend, Hannah M Klinger, et al.
Pageof 5